Concord Biotech Announces Record Date and Book Closure for Final Dividend Ahead of AGM
Concord Biotech Limited has announced key operational dates concerning its upcoming 41st Annual General Meeting (AGM), including the record date and book closure period for determining the entitlement of members to receive the final dividend for the financial year ended March 31, 2026.The company is scheduled to hold its 41st AGM on Friday, July 31, 2026, at 12:00 Noon IST. The meeting will be conducted through Video Conferencing or Other Audio Visual Means.
To facilitate the disbursement of the final dividend, Concord Biotech has set the Record Date as Friday, July 24, 2026. Correspondingly, the Register of Members and Share Transfer Books of the Company will be closed from Saturday, July 25, 2026, to Friday, July 31, 2026.
The company indicated that if the dividend is approved by members at the AGM, the payment to shareholders is expected to be distributed by August 30, 2026, subject to the deduction of tax at source.
Key event details for Concord Biotech Limited are summarized in the table below:
| Indicator | NSE : CONCORDBIO / BSE : 543960 |
|---|---|
| AGM Date | Friday, July 31, 2026, at 12:00 Noon |
| Record Date | Friday, July 24, 2026 |
| Book Closure Period | Saturday, July 25, 2026, to Friday, July 31, 2026 (Both days inclusive) |
| Purpose of AGM | Payment of Final Dividend for the Financial Year ended March 31, 2026 |
CONCORDBIO Stock Price Movement
Shares of Concord Biotech Limited today slipped by 1.06% to settle at ₹1272.6, finishing in decline after trading below its previous closing levels. The stock recorded a total traded volume of 97,930 shares during post-market activity.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.